PT4 stage II and III colon cancers carry the worst prognosis in a nationwide survival analysis. Shepherd's local peritoneal involvement revisited

International Journal of Cancer

Volumn 135, Issue 2, 2014, Pages 467-478

  Snaebjornsson, P ^a,b   Coupe, V M H ^a   Jonasson, L ^b,c   Meijer, G A ^a   Van Grieken, N C ^a   Jonasson, J G ^b,c,d  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^c UNIVERSITY OF ICELAND   (Iceland)

^d ICELANDIC CANCER REGISTRY   (Iceland)

Author keywords

colorectal cancer; local peritoneal involvement; pathology; prognosis; T4

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURVIVAL; COLON CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL TIME; TUMOR DIFFERENTIATION; TUMOR INVASION; VERY ELDERLY;

COLORECTAL CANCER; LOCAL PERITONEAL INVOLVEMENT; PATHOLOGY; PROGNOSIS; T4;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; FEMALE; HUMANS; ICELAND; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; PERITONEAL NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84900000688     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28676     Document Type: Article

References (50)

1. Gunderson LL, Jessup JM, Sargent DJ, et al. Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol 2010; 28: 264-71.
2. Hammond ME, Fitzgibbons PL, Compton CC, et al. College of American Pathologists Conference XXXV: solid tumor prognostic factors-which, how and so what? Summary document and recommendations for implementation. Arch Pathol Lab Med 2000; 124: 958-65.
3. O'Connor ES, Greenblatt DY, LoConte NK, et al. Adjuvant chemotherapy for stage II colon cancer with poor prognostic features. J Clin Oncol 2011; 29: 3381-8.
4. Compton CC, Fielding LP, Burgart LJ, et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000; 124: 979-94.
5. Baxter NN, Ricciardi R, Simunovic M, et al. An evaluation of the relationship between lymph node number and staging in pT3 colon cancer using population-based data. Dis Colon Rectum 2010; 53: 65-70.
6. Benedix F, Kube R, Meyer F, et al. Comparison of 17,641 patients with right- and left-sided colon cancer: Differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum 2010; 53: 57-64.
7. Comprehensive Cancer Centres the Netherlands. Oncoline. Available from: http://www.oncoline.nl/coloncarcinoom [cited 2013 Feb 11]. Dutch.
8. Washington MK, Berlin J, Branton PA, et al. Protocol for the examination of specimens from patients with primary carcinomas of the colon and rectum. Arch Pathol Lab Med 2008; 132: 1182-93.
9. Williams GT, Quirke P, Shepherd NA,. Dataset for colorectal cancer, 2nd ed. London: The Royal College of Pathologists; 2007. p. 1-27. Available from: http://www.rcpath.org.
10. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Colon Cancer, 3rd ed. 2012. 1-120.
11. Association of Coloproctology of Great Britain and Ireland. Guidelines for the management of colorectal cancer (2007), 3rd ed. 2007. Available from: http://www.acpgbi.org.uk.
12. Stewart CJR, Hillery S, Platell C, et al. Assessment of serosal invasion and criteria for the classification of pathological (p) T4 staging in colorectal carcinoma: confusions, controversies and criticisms. Cancers 2011; 3: 164-81.
13. Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 2003; 21: 2912-9.
14. Hermanek P, Guggenmoos-Holzmann I, Gall FP,. Prognostic factors in rectal carcinoma. A contribution to the further development of tumor classification. Dis Colon Rectum 1989; 32: 593-9.
15. Wittekind C, Greene FL, Henson DE, et al, editors. TNM Supplement, 3rd edn. New York: Wiley, 2003. 42 p.
16. Passman MA, Pommier RF, Vetto JT,. Synchronous colon primaries have the same prognosis as solitary colon cancers. Dis Colon Rectum 1996; 39: 329-34.
17. Abe S, Terai T, Sakamoto N, et al. Clinicopathological features of nonpolypoid colorectal tumors as viewed from the patients' background. J Gastroenterol 2006; 41: 325-31.
18. Hamilton SR, Vogelstein B, Kudo S, et al. Carcinoma of the colon and rectum. In:, Hamilton SR, Aaltonen LA, eds. World Health Organization classification of tumours. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press; 2000. 103-43.
19. Jass JR, Ajioka Y, Allen JP, et al. Assessment of invasive growth pattern and lymphocytic infiltration in colorectal cancer. Histopathology 1996; 28: 543-8.
20. Greene FL, Page DL, Fleming ID, et al, editors. Colon and rectum. In: AJCC cancer staging handbook, 6th edn. New-York: Springer-Verlag; 2002. 113-23.
21. Shepherd NA, Baxter KJ, Love SB,. The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology 1997; 112: 1096-102.
22. Petersen VC, Baxter KJ, Love SB, et al. Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer. Gut 2002; 51: 65-9.
23. Birgisson H, Talbäck M, Gunnarsson U, et al. Improved survival in cancer of the colon and rectum in Sweden. Eur J Surg Oncol 2005; 31: 845-53.
24. Gatta G, Ciccolallo L, Capocaccia R, et al. Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology. Eur J Cancer 2003; 39: 2214-22.
25. Masoomi H, Ziogas A, Lin BS, et al. Population-based evaluation of adenosquamous carcinoma of the colon and rectum. Dis Colon Rectum 2012; 55: 509-14.
26. Ottenbacher KJ, Ottenbacher HR, Tooth L, et al. A review of two journals found that articles using multivariable logistic regression frequently did not report commonly recommended assumptions. J Clin Epidemiol 2004; 57: 1147-52.
27. Tang LH, Berlin J, Branton P, et al. CAP protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum, 2013. 1-28. Available from: http://www.cap.org.
28. Gill S, Loprinzi CL, Sargent DJ, et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol 2004; 22: 1797-806.
29. Merkel S, Wein A, Günther K, et al. High-risk groups of patients with Stage II colon carcinoma. Cancer 2001; 92: 1435-43.
30. Keshava A, Chapuis PH, Chan C, et al. The significance of involvement of a free serosal surface for recurrence and survival following resection of clinicopathological stage B and C rectal cancer. Colorectal Dis 2007; 9: 609-18.
31. Merok MA, Ahlquist T, Royrvik EC, et al. Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series. Ann Oncol 2013; 24: 1274-82.
32. Morris M, Platell C, de Boer B, et al. Population-based study of prognostic factors in stage II colonic cancer. Br J Surg 2006; 93: 866-71.
33. Betge J, Pollheimer MJ, Lindtner RA, et al. Intramural and extramural vascular invasion in colorectal cancer. Cancer 2012; 118: 628-38.
34. Baumhoer D, Thiesler T, Maurer CA, et al. Impact of using elastic stains for detection of venous invasion in the prognosis of patients with lymph node negative colorectal cancer. Int J Colorectal Dis 2010; 25: 741-6.
35. Harris EI, Lewin DN, Wang HL, et al. Lymphovascular invasion in colorectal cancer: an interobserver variability study. Am J Surg Pathol 2008; 32: 1816-21.
36. Quirke P, Morris E,. Reporting colorectal cancer. Histopathology 2007; 50: 103-12.
37. Danish Colorectal Cancer Group (DCCG). Aarsrapport 2011. Available from: http://www.dccg.dk [cited 2013 Feb 18]. Danish.
38. Maerkl B, Rossle J, Arnholdt HM, et al. The clinical significance of lymph node size in colon cancer. Mod Pathol 2012; 25: 1413-22.
39. Ogino S, Nosho K, Irahara N, et al. Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype. Clin Cancer Res 2009; 15: 6412-20.
40. Morikawa T, Kuchiba A, Qian ZR, et al. Prognostic significance and molecular associations of tumor growth pattern in colorectal cancer. Ann Surg Oncol 2012; 19: 1944-53.
41. Diez M, Pollán M, Enriquez JM, et al. Histopathologic prognostic score in colorectal adenocarcinomas. Anticancer Res 1998; 18: 689-94.
42. Verhulst J, Ferdinande L, Demetter P, et al. Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis. J Clin Pathol 2012; 65: 381-8.
43. Deschoolmeester V, Baay M, Specenier P, et al. A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy. Oncologist 2010; 15: 699-731.
44. Börger ME, Gosens M, Jeuken J, et al. Signet ring cell differentiation in mucinous colorectal carcinoma. J Pathol 2007; 212: 278-86.
45. Mekenkamp LJM, Heesterbeek KJ, Koopman M, et al. Mucinous adenocarcinomas: poor prognosis in metastatic colorectal cancer. Eur J Cancer 2012; 48: 501-9.
46. Jess P, Hansen IO, Gamborg M, et al. A nationwide Danish cohort study challenging the categorisation into right-sided and left-sided colon cancer. BMJ Open 2013; 3: e002608.
47. Meguid RA, Slidell MB, Wolfgang CL, et al. Is there a difference in survival between right- versus left-sided colon cancers? Ann Surg Oncol 2008; 15: 2388-94.
48. Alexiusdottir KK, Möller PH, Snaebjornsson P, et al. Association of symptoms of colon cancer patients with tumor location and TNM tumor stage. Scand J Gastroenterol 2012; 47: 795-801.
49. Haraldsson S, Möller PH, Jonasson JG, et al. Use of adjuvant chemotherapy in patients with stage III colon cancer in Iceland (1995-2004) [abstract]. Scand J Gastroenterol 2012; 47: P22.
50. Stefansdottir H, Möller PH, Stefansson TB, et al. [Colon cancer in LSH 1994-1998] [abstract]. Læknaneminn 2005; 56: 92. Icelandic.